CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Shared and context-specific mechanisms of T cell exhaustion in chronic viral infections and cancer: Transcriptional, metabolic, epigenetic, and therapeutic perspectives.
Shared and context-specific mechanisms of T cell exhaustion in chronic viral infections and cancer: Transcriptional, metabolic, epigenetic, and therapeutic perspectives.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
T细胞通过清除感染或转化细胞并建立免疫记忆,在抵御病毒感染和癌症方面至关重要。然而,慢性感染或肿瘤中的持续抗原刺激会使T细胞进入功能障碍状态,即耗竭。其特征包括增殖及效应功能降低、PD-1、LAG-3和CTLA-4等抑制性受体上调,以及转录、表观遗传和代谢程序改变。T细胞耗竭既由内在因素驱动,包括转录因子网络变化和代谢功能障碍;也受外在因素影响,如持续抗原暴露和免疫抑制性微环境。PD-1、TOX和TCF-1等关键分子参与该过程,但慢性病毒感染和癌症中内外信号之间复杂的相互作用仍未充分阐明。本综述总结HIV、HBV及SARS-CoV-2等慢性病毒感染以及肿瘤中的T细胞耗竭,强调共享机制和情境特异差异。
我们重点讨论转录网络、代谢变化、免疫检查点及耗竭相关信号的作用,并依据近期高影响力研究介绍免疫检查点抑制剂、CAR-T 细胞疗法、细胞因子补充及代谢干预等新兴治疗策略。通过整合慢性感染和癌症领域认识,本综述旨在识别T细胞耗竭的共同规律,并提出改善慢性病毒病及癌症免疫治疗结局的策略。
T cells are crucial for defending against viral infection and cancer by eliminating infected or transformed cells and establishing immune memory.
However, persistent antigenic stimulation in chronic infections or tumors drives T cells into a dysfunctional state known as exhaustion. This state is characterized by reduced proliferation and effector functions, upregulation of inhibitory receptors like PD-1, LAG-3, and CTLA-4, and alterations in transcriptional, epigenetic, and metabolic programs. T cell exhaustion is driven by both intrinsic factors, including changes in transcription factor networks and metabolic dysfunction, and extrinsic factors, such as continuous antigen exposure and an immunosuppressive microenvironment.
Key molecules like PD-1, TOX, and TCF-1 are central to this process, though the complex interactions between intrinsic and extrinsic signals in chronic viral infections and cancers remain poorly understood. This review summarized T cell exhaustion in chronic viral infections, such as HIV, HBV, and SARS-CoV-2, as well as in tumors, emphasizing shared mechanisms and context-specific differences.
We focused on the roles of transcriptional networks, metabolic changes, immune checkpoints, and exhaustion-related signaling.
Additionally, we discussed emerging therapeutic strategies, such as immune checkpoint inhibitors, CAR-T cell therapies, cytokine supplementation, and metabolic interventions, based on recent high-impact studies. By integrating insights from both chronic infection and cancer, this review aims to identify common principles of T cell exhaustion and propose strategies to improve clinical outcomes in chronic viral diseases and cancer immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。